Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.
about
Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Inflammatory process in Alzheimer's DiseaseA novel neurotrophic drug for cognitive enhancement and Alzheimer's diseaseProlonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Presenilin/gamma-Secretase and Inflammation.Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain.Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Staging anti-inflammatory therapy in Alzheimer's disease.Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.Thinking outside the box about COX-1 in Alzheimer's disease.A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease
P2860
Q26822022-39DB9DB7-C704-46D9-BF83-0E7655408720Q27500412-C7CAE220-99AC-49DB-AAAF-0DC1F1790461Q28478380-9A7E686B-B037-41A0-8BBA-E52D6800D8F9Q30506148-3F2B0B6A-FA32-4DC2-86DF-7EBB6F75D6A9Q33918695-ECCF9E99-F301-458F-9F7C-ECD7EAB48082Q37043088-195E764D-DB86-498E-8597-CDA4B5857D7CQ37051783-B2E8DBAD-0FB6-4FA4-9F3A-BE8C4D47514CQ37179784-3BE484D4-7554-4C04-A34A-BF8223706EBDQ37190465-4B2ABC95-BDA8-4A21-8DAB-59606256059CQ37193054-9BB91D6A-BEF3-4591-A01B-5274B37453F8Q37678539-5BB96FCB-D13A-46E9-A2B2-77127AB6F23CQ37703299-863CEE7A-7A10-4953-8887-F12A99F1AE26Q41179524-BFC251B5-3020-44E6-AE3E-7E9DE01EFAA8Q41574477-B2F8756A-0DC8-47AA-9E49-4F1BB361A72EQ41872008-F2A8752E-9C65-4EB7-99C3-14E1710305F4Q58797402-9C85C989-81EC-4E9F-B5A3-2DCBE81F906E
P2860
Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@en
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@nl
type
label
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@en
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@nl
prefLabel
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@en
Triflusal reduces dense-core p ...... model of Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Triflusal reduces dense-core p ...... e model of Alzheimer's disease
@en
P2093
B Da Rocha-Souto
B J Bacskai
L A Borrelli
M B Sánchez
P2860
P304
P356
10.1016/J.NBD.2010.01.019
P577
2010-02-10T00:00:00Z